Compare Sinar Eka Selaras Tbk. (ERAL) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinar Eka Selaras Tbk. vs Merck Tbk. — how do they compare? Sinar Eka Selaras Tbk. trades at Rp320 (market cap 1.67T, 6.96M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Sinar Eka Selaras Tbk. and Merck Tbk. are close in size by market cap, and Sinar Eka Selaras Tbk. is more actively traded (6.96M versus 63K). Which is the better fit depends on your goals.
| ERAL | MERK | |
|---|---|---|
Market Cap | 1.67T | 1.76T |
Volume | 6.96M | 63K |
Lot | 69.56K | 630 |
Turnover | 2.22B | 243.97M |
Average Price | 319.06 | 3,872.46 |
Value | 2.22B | 243.97M |
Indicative Equilibrium Price | 320 | 3,900 |
Indicative Equilibrium Volume | 1.31K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
